Full Text View
Tabular View
No Study Results Posted
Related Studies
Immunogenicity & Safety Study of GSK Biologicals' 208136 Vaccine Formulated With New Measles and Rubella Working Seeds
This study has been completed.
Study NCT00892775   Information provided by GlaxoSmithKline

First Received on May 4, 2009.   Last Updated on June 1, 2011   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Additional conditions recognized in this trial
More general conditions related to this trial
Sponsors listed in this trial